Michael Hill, MD
Psychiatry · Lebanon, TNNPI 1174568349
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,850 of the $40,932 with a category attached, or 87.6%. AbbVie accounts for 97.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $16,313 and has fallen 99.4% since, to $104 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $322.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$40K
- Tris Pharma Inc$310
- Sunovion Pharmaceuticals Inc.$152
- Alkermes, Inc.$133
- Otsuka America Pharmaceutical, Inc.$117
- Neurocrine Biosciences, Inc.$74
- plus $126 from 5 others
What the payments were for
- Speaking & faculty fees$35,85088%
- Travel & lodging$3,2878%
- Food & beverage$1,7954%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $40,019 |
| Tris Pharma Inc | 4 | $310 |
| Sunovion Pharmaceuticals Inc. | 8 | $152 |
| Alkermes, Inc. | 6 | $133 |
| Otsuka America Pharmaceutical, Inc. | 7 | $117 |
| Neurocrine Biosciences, Inc. | 4 | $74 |
| Johnson & Johnson | 3 | $55 |
| Shire North American Group Inc | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$39,142
- Dyanavel XR$104
How this compares
$40,932 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 22 | $29,916 |
| RexultiBrexpiprazole | 12 | $18,989 |
| TrintellixVortioxetine Hydrobromide | 20 | $17,395 |
| Aripiprazole | 86 | $4,597 |
| Perphenazine | 28 | $2,645 |
| Vilazodone Hcl | 12 | $1,773 |
| Quetiapine Fumarate | 94 | $1,642 |
| Hydroxyzine Hcl | 49 | $1,282 |
| Divalproex Sodium | 36 | $1,254 |
| Bupropion XlBupropion Hcl | 64 | $1,210 |
| Oxcarbazepine | 26 | $1,200 |
| Clomipramine Hcl | 19 | $1,181 |
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 12 | $1,081 |
| Buspirone Hcl | 43 | $995 |
| Risperidone | 68 | $973 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $40,019 | $29,91622 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $117 | $18,98912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 503 psychiatry providers in Tennessee.
Other psychiatry in Lebanon
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- John FenleyJohnson City$1.4M
- David SnowMaryville$605K
- Karthi NamasivayamKnoxville$225K
- Robert JamiesonNashville$141K
- George BrownJohnson City$91K
- Sricharan MoturiFranklin$82K
- Michelle CochranNashville$74K
- Daniel BoydMemphis$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.